According to these schools, a doctor remembers that, in earlier cases, symptom A was alleviated by medication B. They do not infer that medication B makes symptom A disappear, or that the illness C is the cause of symptom A. Second, the Five Modes do not exclusively target proof.
Two areas of application were targeted as proof of principle: (A) selective product recovery in nanocompartments and (B) enzymatic conversion in nanocompartments.
We searched for gene expression changes affecting key cell signalling pathways that may be targeted as proof of principle in a CRPC in vitro cell line model.
Many native peoples became prey of European countries, companies, and colonies, and of Americans, whose bounty proclamations set targets, proof of "Indian kill" and prices.
Clinically, target occupancy can be used to unequivocally confirm "drug-on-target" (proof of mechanism), (Morgan et al. 2012) guide clinical dose selections, and enable data-driven clinical "Go/No Go" decisions depending on whether the onset of side effects occurs prior to or after desired target occupancy range for efficacy (Wong et al. 2009).
Use of PD biomarkers in early clinical trials extends hypothesis testing and confirms whether a drug hits a tumour target (proof of mechanism, POM) and thereafter, the anticipated tumour outcome is reached (proof of concept, POC).
Due to the cancer heterogeneity, different tumor models will be needed according to the development stages: target validation, proof of concept of target inhibition by a lead compound (small molecules or biotherapeutics), or candidate selection for further clinical development.
Similarly, several cancer-related genes have been targeted in proof-of-principle experiments, including cellular oncogenes and drug resistance genes.
We have again targeted CIITA as proof or principle, but we recognize that multiple molecules may need to be simultaneously targeted to get the full benefits of graft modulation.
This work was targeted as a proof of concept study and therefore has limitations in providing information about the exact mechanisms which led to the observed results, e.g. a possible dose-dependent effect of BMP-2.
Notwithstanding these difficulties, murine models can represent useful tools for target validation and proof-of-concept studies for novel tumour-specific antigens.
